These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 9083829)

  • 41. Study of different HILIC, mixed-mode, and other aqueous normal-phase approaches for the liquid chromatography/mass spectrometry-based determination of challenging polar pesticides.
    Vass A; Robles-Molina J; Pérez-Ortega P; Gilbert-López B; Dernovics M; Molina-Díaz A; García-Reyes JF
    Anal Bioanal Chem; 2016 Jul; 408(18):4857-69. PubMed ID: 27178548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of boronic acids by nano liquid chromatography-direct electron ionization mass spectrometry.
    Flender C; Leonhard P; Wolf C; Fritzsche M; Karas M
    Anal Chem; 2010 May; 82(10):4194-200. PubMed ID: 20411924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Applications and progresses of liquid chromatography-mass spectrometry in doping control].
    Qin Y; Xu Y; Yang S; Zhu S
    Se Pu; 2008 Jul; 26(4):431-6. PubMed ID: 18959237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-resolution mass spectrometry in toxicology: current status and future perspectives.
    Maurer HH; Meyer MR
    Arch Toxicol; 2016 Sep; 90(9):2161-2172. PubMed ID: 27369376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry.
    Niessen WM
    Mass Spectrom Rev; 2011; 30(4):626-63. PubMed ID: 21294151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drugs in oral fluid Part I. Validation of an analytical procedure for licit and illicit drugs in oral fluid.
    Wylie FM; Torrance H; Anderson RA; Oliver JS
    Forensic Sci Int; 2005 Jun; 150(2-3):191-8. PubMed ID: 15944059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proof of cannabis administration by sensitive detection of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in hair using selective methylation and application of liquid chromatography- tandem and multistage mass spectrometry.
    Thieme D; Sachs H; Uhl M
    Drug Test Anal; 2014; 6(1-2):112-8. PubMed ID: 24424857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods.
    Viette V; Fathi M; Rudaz S; Hochstrasser D; Veuthey JL
    Clin Chem Lab Med; 2011 Jul; 49(7):1091-103. PubMed ID: 21504375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of liquid chromatography/quadrupole-linear Ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater.
    Bueno MJ; Agüera A; Gómez MJ; Hernando MD; García-Reyes JF; Fernandez-Alba AR
    Anal Chem; 2007 Dec; 79(24):9372-84. PubMed ID: 18001124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS.
    Nielsen MK; Johansen SS; Dalsgaard PW; Linnet K
    Forensic Sci Int; 2010 Mar; 196(1-3):85-92. PubMed ID: 20061098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Direct analysis in real time-Mass spectrometry (DART-MS) in forensic and security applications.
    Pavlovich MJ; Musselman B; Hall AB
    Mass Spectrom Rev; 2018 Mar; 37(2):171-187. PubMed ID: 27271453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microfluidic chip-based liquid chromatography coupled to mass spectrometry for determination of small molecules in bioanalytical applications.
    Lin SL; Bai HY; Lin TY; Fuh MR
    Electrophoresis; 2012 Feb; 33(4):635-43. PubMed ID: 22451056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fragmentation of toxicologically relevant drugs in negative-ion liquid chromatography-tandem mass spectrometry.
    Niessen WM
    Mass Spectrom Rev; 2012; 31(6):626-65. PubMed ID: 22829116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous Screening and Quantification of Basic, Neutral and Acidic Drugs in Blood Using UPLC-QTOF-MS.
    Bidny S; Gago K; Chung P; Albertyn D; Pasin D
    J Anal Toxicol; 2017 Apr; 41(3):181-195. PubMed ID: 27881618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemical derivatization for forensic drug analysis by GC- and LC-MS.
    Lin DL; Wang SM; Wu CH; Chen BG; Liu RH
    Forensic Sci Rev; 2016 Jan; 28(1):17-35. PubMed ID: 26841721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for screening of urine specimens for 100 analytes relevant in drug-facilitated crime (DFC).
    Remane D; Wetzel D; Peters FT
    Anal Bioanal Chem; 2014 Jul; 406(18):4411-24. PubMed ID: 24817357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ESI-MS-MS library of 1,253 compounds for application in forensic and clinical toxicology.
    Sauvage FL; Marquet P
    Anal Bioanal Chem; 2010 Mar; 396(5):1947. PubMed ID: 20107771
    [No Abstract]   [Full Text] [Related]  

  • 58. Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control.
    Maurer HH
    J Mass Spectrom; 2006 Nov; 41(11):1399-413. PubMed ID: 17051522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Requirements for bioanalytical procedures in postmortem toxicology.
    Drummer OH
    Anal Bioanal Chem; 2007 Aug; 388(7):1495-503. PubMed ID: 17377776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.